TABLE III.
Variable | Value |
---|---|
Radiation site [n (%)] | |
Bone | 1731 (72.49) |
Central nervous system | 456 (19.10) |
Thoracic | 95 (3.98) |
Gastrointestinal | 29 (1.21) |
Breast | 15 (0.63) |
Genitourinary | 13 (0.54) |
Others | 49 (2.05) |
Treatment overall | |
20 Gy in 5 fractions | 1087 (45.52) |
8 Gy in 1 fraction | 1042 (43.63) |
30 Gy in 10 fractions | 135 (5.65) |
Others | 124 (5.19) |
Treatment for pain (bone metastases), n=1062 | |
8 Gy in1 fractions | 690 (64.97) |
20 Gy in 5 fractions | 284 (26.74) |
30 Gy in 10 fractions | 40 (3.77) |
Others | 48 (4.52) |
Treatment for brain metastases, n=420 | |
20 Gy in 5 fractions | 365 (86.90) |
30 Gy in 10 fractions | 28 (6.67) |
8 Gy in 1 fraction | 10 (2.38) |
Others | 17 (4.05) |
Referred with and received treatment for, n=1957 | |
Pain (bone metastases) | 1062 (54.27) |
Brain metastases | 420 (21.46) |
Post surgery | 74 (3.78) |
Mass | 68 (3.47) |
Lesion in diagnostic imaging | 53 (2.71) |
Spinal cord compression (scc) | 44 (2.25) |
Bleeding | 35 (1.79) |
Cauda equina syndrome | 23 (1.18) |
Assess need for more treatment | 22 (1.12) |
Impending scc | 22 (1.12) |
Pathologic fracture | 16 (0.82) |
Pain (other) | 14 (0.72) |
Assess rt response | 13 (0.66) |
Shortness of breath | 11 (0.56) |
Symptoms of svco | 8 (0.41) |
Pain (neuropathic) | 6 (0.31) |
Impending fracture | 4 (0.20) |
Other | 62 (3.17) |
rt = radiotherapy; svco = superior vena cava obstruction; bmc = bone metastases clinic.